Latest news with #DayOne
Yahoo
6 hours ago
- Business
- Yahoo
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
BRISBANE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) ('Day One' or the 'Company'), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, August 5, 2025 at 4:30 p.m. ET to report financial results and discuss corporate progress for the second quarter 2025. Live audio of the webcast will be accessible on Day One's Events on the Day One Media & Investors page. An archived version of the webcast will be available for replay on the News & Events section of the Day One Media & Investors page for 30 days following the event. About Day One Biopharmaceuticals Day One Biopharmaceuticals believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by 'The Day One Talk' that physicians have with patients and their families about an initial cancer diagnosis and treatment, Day One aims to re-envision cancer drug development and redefine what's possible for all people living with cancer – regardless of age – starting from day one. Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company's pipeline includes tovorafenib (OJEMDA™) and DAY301. Day One is based in Brisbane, California. For more information, please visit or find the Company on LinkedIn or X. Day One uses its Investor Relations website ( its X handle ( and LinkedIn Home Page ( as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD. DAY ONE MEDIALaura Cooper, Head of Communicationsmedia@ DAY ONE INVESTORSLifeSci Advisors, PJ Kelleherpkelleher@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Daily Mirror
6 days ago
- Health
- Daily Mirror
Lupita Nyong'o reveals secret decade-long health battle in candid post
A Quiet Place: Day One actor Lupita Nyong'o opened up about her decade-long health battle in a new candid post shared on social media Award-winning actress Lupita Nyong'o said, "Silence serves no one", as she candidly opened up about being diagnosed with chronic uterine fibroids. The Us actor said she had been secretly battling the condition, which are non-cancerous growths that develop in or around the womb, for a decade According to the NHS website, many women are unaware they have fibroids because they do not have any symptoms. Those who do have symptoms could experience heavy/painful periods, abdominal pain, lower back pain, a frequent need to pee, constipation and discomfort during sex. In some rare cases, further complications caused by fibroids can affect pregnancy READ MORE: 'Life changing' 48p-a-day supplement that gets rid of fatigue and leaves tummy 'flatter' In a new post shared on her Instagram page, Lupita, 42, said she was "speaking up" about her story. Along with a series of snaps, she said she hoped her experience would 'resonate with anyone else who has ever felt dismissed, confused or alone'. "And I hope to seek answers for the far too many women dealing with uterine fibroids (80% of Black women and 70% of white women by age 50!). We deserve better. It's time to demand it. Silence serves no one," she wrote. The star added: "1. Today, I joined Congresswomen @repshontel, @repyvetteclarke, @repbonnie, @reprobinkelly and Senators @sen_alsobrooks and @senlbr in Washington DC to introduce a package of uterine fibroid Congressional bills. These bills would expand research funding, increase early detection and interventions for uterine fibroids, study the causes of uterine cancer, and increase public awareness. "2. In partnership with the Foundation for Women's Health, I'm launching the FWH x Lupita Nyong'o Uterine Fibroid Research Grant. @foundationwomenshealth will seek research proposals to develop minimally invasive or non-invasive treatments for uterine fibroids to reduce symptoms and improve quality of life for the 15 million patients suffering from this chronic condition in the U.S. alone." The first photo was taken of her at the Oscars in 2014 when she won an award. She said she learned of her uterine fibroids that very same year. She had surgery to remove 30 fibroids and asked her doctor whether there's anything she could do to prevent them from recurring. Her doctor told her: "You can't. It's only a matter of time until they grown again." The star went on to share symptoms of fibroids, reminding readers that some people have no symptoms at all. Lupita added: "8 out of 10 Black women and 7 out of 10 white women will experience fibroids. Yet we speak so little of them." "When we reach puberty, we're taught that periods mean pain, and that pain is simply part of being a woman. I started talking about my experience privately, and I realised so many women are going through this. We're struggling alone with something that affects most of us. No more suffering in silence!" the A Quiet Place: Day One actor added. Lupita said people have to stop treating the condition as a 'series of unfortunate coincidences' as she told followers: "We must reject the normalisation of female pain. I envision a future with early education for teenagers, better screening protocols, robust prevention research, and less invasive treatments for uterine fibroids." After opening up about her work to better the future for women's health, friends took to the comment section to praise the star. Kerry Washington posted: "Brava Lupita. This is so brave and so beautiful," while Nigerian actress Ini Edo said: "The untold woes of womanhood … Be encouraged sis." Catwoman icon Halle Berry added: "This is such important info to share ! Thank you my friend." Gabrielle Union wrote: "Thank you for sharing this and helping so many of us suffering in silence! Love you mama," and Jessica Alba commented: "You are so brave for sharing -we absolutely need more funding for women's health."
CNBC
6 days ago
- Business
- CNBC
This data center stock will be a winner as Nvidia resumes China shipments, JPMorgan says
Shares of GDS Holdings may see a boost as artificial intelligence darling Nvidia resumes shipments to China, according to JPMorgan. The firm upgraded the data center stock to overweight from neutral and raised its price target to $46 from $34. That updated target calls for about 22% upside from Monday's closing level. Earlier this week, Nvidia said that it hopes to start deliveries of its H20 general processing units "soon" after the U.S. government assured it that licenses would be granted. The company halted sales back in April after the U.S. government said that it would need a license to sell the chips to China. "We are upgrading GDS to OW, given the resumption of H20 shipments into China … should drive an upside case for the domestic DC business," analyst Gokul Hariharan wrote. "Demand indications from Tier-1 [cloud solution provider] customers remain quite strong for AI inference compute (as seen by the 150 MW order from Alibaba in 1Q25) and we see a pathway to continued upgrades in the China pipeline and revenue growth." U.S.-listed shares of the China-based company were more than 1% higher in the premarket following the move. Shares have also rallied more than 90% in the past three months and around 66% in the past six. GDS 3M mountain GDS, 3-month The analyst also noted that although capacity for AI training compute in China could be "balanced or in mild oversupply" due to an "aggressive" buildout in remote locations such as Ulanqab, he thinks that GDS has "very limited" exposure to that area of the market. Even with some oversupply, there could be some pricing upside next year as more AI inference demand kicks in, he added. Beyond China, the analyst said that GDS's international business has been "quite strong" and thinks that its international arm known as DayOne should continue to see gains even with rumblings of GPU restrictions in countries like Malaysia. "We believe that aggregate growth for DayOne … should continue, given the opening up of new markets (Thailand, Europe) and continued strong demand from its largest Chinese social media customer," Hariharan also wrote. Most of Wall Street is similarly bullish on the name, as 17 out of 18 analysts have a strong buy or buy rating, LSEG data shows. Its consensus target of almost $45 also implies more than 18% upside from here.
The Star
7 days ago
- Business
- The Star
Malaysia to be focus of DayOne's plans
ISKANDAR PUTERI: Global data centre operator DayOne is deepening its long-term commitment to Malaysia by positioning the country as a key hub in the regional digital supply chain, with major investments centred on Johor. DayOne Data Centers Malaysia Sdn Bhd general manager Jimmy Yan said the company is currently developing two hyperscale campuses in Nusajaya Tech Park and Kempas Tech Park, each covering hundreds of acres and targeting a combined capacity of up to 500 megawatts. 'Our goal is not just to build data centres, but to embed ourselves in Malaysia's digital economy by localising our supply chain, developing skilled local talent, and building long-term partnerships with both federal and state governments,' Yan said. According to Yan, the project is already generating significant economic spillover, with an estimated RM400mil in supply-chain investments already. — Bernama
Barnama
15-07-2025
- Business
- Barnama
DayOne Drives Digital Supply Chain Investments In Johor, Positions Malaysia As Regional Hub
BUSINESS By Hasnah Jusid ISKANDAR PUTERI, July 15 (Bernama) -- Global data centre operator DayOne is deepening its long-term commitment to Malaysia by positioning the country as a key hub in the regional digital supply chain, with major infrastructure and ecosystem investments centred in Johor. DayOne Data Centers Malaysia Sdn Bhd general manager Jimmy Yan said the company is currently developing two hyperscale campuses in Nusajaya Tech Park and Kempas Tech Park, each covering hundreds of acres and targeting a combined capacity of up to 500 megawatts. 'Our goal is not just to build data centres, but to embed ourselves in Malaysia's digital economy by localising our supply chain, developing skilled local talent, and building long-term partnerships with both federal and state governments,' he told Bernama in an exclusive interview. According to Jimmy, the project is already generating significant economic spillover, with an estimated RM400 million ringgit in supply chain investments already recorded, driven by the localisation of vendors and partners. He added that DayOne aims to transition from 'investing in Malaysia to 'Made in Malaysia'', making the country not just a base for operations but a core manufacturing and supply chain hub for the company's global infrastructure needs. 'We are bringing in our ecosystem, not only our hyperscale clients and technology (tech) giants, but also artificial intelligence (AI) startups and application developers to set up regional operations here,' he said. Jimmy also said the company's presence in Johor is closely aligned with the state's push under the Special Economic Zone (SEZ) framework, further reinforcing Johor's status as an emerging digital powerhouse. In terms of employment, DayOne is projected to create around 1,000 direct jobs and up to 5,000 indirect jobs over the next few years through its contractors, suppliers, and ecosystem partners.
